TRPS1 immunohistochemical expression in salivary gland tumors: A pilot study
American Journal of Clinical Pathology · 2023
DOI: 10.1093/ajcp/aqad100 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2023. Verfasst von Youley Tjendra und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, US. Hauptthemen laut MEDLINE: Adenoma, Pleomorphic, Carcinoma, Carcinoma, Adenoid Cystic, Adenoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Objectives
TRPS1 is a new, sensitive marker for breast carcinoma (BC). Salivary glands and breasts are both exocrine glands; thus, their tumors may share similar morphology and immunophenotype. Among salivary gland–type BC, TRPS1 is reported to be positive in secretory carcinomas (SCs) but negative in acinic cell carcinomas (AciCCs) and most adenoid cystic carcinomas (AdCCs). A subset of salivary duct carcinomas (SDCs) is positive for TRPS1. Herein, we investigate TRPS1 immunohistochemical expression in salivary gland tumors (SGTs).
Methods
A retrospective search yielded 110 SGTs (97 primary and 13 metastatic). TRPS1 immunohistochemistry was scored as negative, low positive, intermediate positive, or strongly positive.
Results
TRPS1 was expressed in 78% (14/18) of pleomorphic adenoma (PA) cases but negative/low positive in all Warthin tumors (6/6 [100%]). In basal cell adenoma (BCA), TRPS1 expression was intermediate to strong (13/14 [92%]) in the stromal cells, whereas ductal or basal cells showed low expression. TRPS1 expression varied in malignant SGTs, with intermediate to strong staining in 100% (15/15) of AdCCs, 100% (5/5) of basal cell adenocarcinoma, 100% (3/3) of intraductal carcinoma, 89% (8/9) of polymorphous adenocarcinoma, and 89% (7/8) of SDCs; negative/low positive expression was observed in 100% (3/3) of SCs, 89% (8/9) of AciCCs, and 50% (3/3) of mucoepidermoid carcinomas. In addition, strong and intermediate TRPS1 expression was observed in metastatic SGT to the lungs, lymph nodes, and soft tissue.
Conclusions
Overall, TRPS1 is strongly expressed in PA as well as malignant and metastatic SGT. In addition, TRPS1 is positive in stromal cells of BCA but negative or low positive in ductal and basal cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL, US.
- Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center and Geisel School of Medicine, Lebanon, NH, US.
ORCID-Profile: Youley Tjendra, Darcy A Kerr, Carmen Gomez-Fernandez, Jaylou M Velez Torres
Zitieren
APA
Tjendra, Y., Kerr, D. A., Gomez-Fernandez, C., & Velez Torres, J. M. (2023). TRPS1 immunohistochemical expression in salivary gland tumors: A pilot study. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqad100
Vancouver
Tjendra Y, Kerr DA, Gomez-Fernandez C, Velez Torres JM. TRPS1 immunohistochemical expression in salivary gland tumors: A pilot study. American Journal of Clinical Pathology. 2023. doi:10.1093/ajcp/aqad100
BibTeX
@article{Tjendra2023,
author = {Tjendra, Youley and Kerr, Darcy A and Gomez-Fernandez, Carmen and Velez Torres, Jaylou M},
title = {TRPS1 immunohistochemical expression in salivary gland tumors: A pilot study},
journal = {American Journal of Clinical Pathology},
year = {2023},
doi = {10.1093/ajcp/aqad100}
}
EUVIMED